A. Orucevic et al., Nitric-oxide production by murine mammary adenocarcinoma cells promotes tumor-cell invasiveness, INT J CANC, 81(6), 1999, pp. 889-896
The role of nitric oxide (NO) in tumor biology remains controversial and po
orly understood. While a few reports indicate that the presence of NO in tu
mor cells or their micro-environment is detrimental for tumor-cell survival
, and consequently their metastatic ability, a large body of data suggests
that NO promotes tumor progression, The purpose of this study was to identi
fy the source of NO in the spontaneously metastasizing C3-L5 murine mammary
-adenocarcinoma model, the role of tumor-derived NO in tumor-cell invasiven
ess, and the mechanisms underlying the invasion-stimulating effects of tumo
r-derived NO. The source of NO was established by immunocytochemical locali
zation of NO synthase (NOS) enzymes in C3-L5 cells in vitro and transplante
d tumors in vivo. An in vitro transwell Matrigel invasion assay was used to
test the invasiveness of C3-L5 cells in the presence or the absence of NO
blocking agents or iNOS inducers (IFN-gamma and LPS), The mechanisms underl
ying the invasion-stimulating effects of tumor-derived NO were examined by
measuring mRNA expression of matrix metalloproteinases (MMP)-2 and -9, and
tissue inhibitors of metalloproteinases (TIMP) 1, 2 and 3 in C3-L5 cells in
various experimental conditions. Results showed that C3-L5 cells expressed
high level of eNOS protein in vitro, and in vivo, both in primary and in m
etastatic tumors. C3-L5 cells also expressed iNOS mRNA and protein when cul
tured in the presence of IFN-gamma and LPS, Constitutively produced NO prom
oted tumor-cell invasiveness in vitro by down-regulating TIMP 2 and TIMP 3,
In addition, there was up-regulation of MMP-2, when extra NO was induced b
y IFN-gamma and LPS, In conclusion, NO produced by C3-L5 cells promoted tum
or-cell invasiveness by altering the balance between MMP-2 and its inhibito
rs TIMP-2 and 3. Thus, our earlier observations of anti-tumor and anti-meta
static effects of NO inhibitors in vivo in this tumor model can be explaine
d, at least in part, by reduced tumor cell invasiveness. (C) 1999 Wiley-Lis
s, Inc.